- Moonlight Newsletter
- Posts
- Microplastics in Testicles?
Microplastics in Testicles?
New research finds that this is not a bad sci-fi plot, but a reality in the pants.
In this week's curation of Moonlighting MD 💼, we’re covering:
đź’ł How Microplastics may be leading to lower fertility rates
đź’Š Ozempic may extend our expiration date
🖥️ AI software is saving the UK government some serious coin
Read the full scoop below 👇👇👇
HEALTH NEWS
Microplastics detected in human testicles troubling researchers
You know what's fun? Microplastics. They're literally everywhere now, even where the sun doesn't shine. A new study in Toxicological Sciences decided to dig into the nitty-gritty of microplastics invading men’s most intimate parts—balls.
The researchers found 12 different types of microplastics in both dog and human testis samples. In dogs, those pesky microplastics were linked to lower sperm counts and reduced testis weight. Yep, it's as bad as it sounds. Check out the full research here.
HEALTH NEWS
Could drugs like Ozempic and Wegovy help people live longer?
Could Ozempic be the magic pill for a longer, healthier life? Scientists are buzzing about GLP-1 receptor agonists like Ozempic, Zepbound, and Mounjaro. These drugs, initially designed for diabetes, show potential in battling chronic diseases and promoting longevity. From reducing inflammation and managing obesity to possibly preventing Alzheimer’s and cancer, their benefits seem endless. But experts warn: they’re not a one-size-fits-all solution. Dive into the fascinating research and the cautious optimism around these “longevity pills” below.
INNOVATION IN MEDICINE
Revolutionary AI Saves British NHS ÂŁ1 Billion
Imagine saving the NHS ÂŁ1 billion a year just by keeping elderly care at home. That's exactly what Cera's AI-led healthcare model promises. This innovative approach, already saving ÂŁ1 million a day, uses predictive tech to cut hospital visits for the elderly by over half, freeing up hospital beds and reducing A&E wait times. Faculty, a top UK tech firm, confirms these savings could triple by 2026. With a rapidly aging population, this model is a game-changer for healthcare.